Executive Vice President, Sanofi Pasteur
Thomas Triomphe leads the company’s vaccines R&D, industrial and commercial operations and drives the teams’ commitment to prevention against infectious diseases, with a portfolio encompassing seasonal influenza vaccines, pediatric combinations, adolescents & adults boosters, meningitis and travel/endemic vaccines, as well as the development of the first preventive intervention against respiratory syncytial virus for all infants and vaccines against COVID-19.
Thomas joined Sanofi Pasteur in 2004 and held various positions at country, regional and global levels, including Global Head of Influenza-Pneumo Franchise, Japan General Manager, and Head of Asia-Pacific region. Prior to his current appointment, Thomas led the Franchise & Product Strategy organization, implementing the global brands model and designing the vaccines business roadmap. Earlier in his career, Thomas worked in banking and strategic consulting.
Thomas holds a master’s in industrial engineering from École Nationale des Ponts et Chaussées and an MBA from INSEAD.
A father of three and an avid runner, Thomas lets off steam by training for long-distance races.
Executive Vice President, Chief People Officer
Executive Vice President, General Medicines
Executive Vice President, Consumer Healthcare
Executive Vice President, Global Industrial Affairs
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Digital Officer
Executive Vice President, Sanofi Genzyme
Executive Vice President, Legal Affairs and General Counsel